Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Ankylosing Spondylitis Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cimzia
      • 1.3.3 Enbrel
      • 1.3.4 Humira
      • 1.3.5 Remicade
      • 1.3.6 Simponi
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Ankylosing Spondylitis Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Ankylosing Spondylitis Drug Market Size
      • 2.1.1 Global Ankylosing Spondylitis Drug Revenue 2014-2025
      • 2.1.2 Global Ankylosing Spondylitis Drug Sales 2014-2025
    • 2.2 Ankylosing Spondylitis Drug Growth Rate by Regions
      • 2.2.1 Global Ankylosing Spondylitis Drug Sales by Regions 2014-2019
      • 2.2.2 Global Ankylosing Spondylitis Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Ankylosing Spondylitis Drug Sales by Manufacturers
      • 3.1.1 Ankylosing Spondylitis Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Ankylosing Spondylitis Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Ankylosing Spondylitis Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ankylosing Spondylitis Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Ankylosing Spondylitis Drug Price by Manufacturers
    • 3.4 Key Manufacturers Ankylosing Spondylitis Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Ankylosing Spondylitis Drug Market
    • 3.6 Key Manufacturers Ankylosing Spondylitis Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Cimzia Sales and Revenue (2014-2019)
      • 4.1.2 Enbrel Sales and Revenue (2014-2019)
      • 4.1.3 Humira Sales and Revenue (2014-2019)
      • 4.1.4 Remicade Sales and Revenue (2014-2019)
      • 4.1.5 Simponi Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Ankylosing Spondylitis Drug Sales Market Share by Type
    • 4.3 Global Ankylosing Spondylitis Drug Revenue Market Share by Type
    • 4.4 Ankylosing Spondylitis Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Ankylosing Spondylitis Drug Sales by Application

    6 United States

    • 6.1 United States Ankylosing Spondylitis Drug Breakdown Data by Company
    • 6.2 United States Ankylosing Spondylitis Drug Breakdown Data by Type
    • 6.3 United States Ankylosing Spondylitis Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Ankylosing Spondylitis Drug Breakdown Data by Company
    • 7.2 European Union Ankylosing Spondylitis Drug Breakdown Data by Type
    • 7.3 European Union Ankylosing Spondylitis Drug Breakdown Data by Application

    8 China

    • 8.1 China Ankylosing Spondylitis Drug Breakdown Data by Company
    • 8.2 China Ankylosing Spondylitis Drug Breakdown Data by Type
    • 8.3 China Ankylosing Spondylitis Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Ankylosing Spondylitis Drug Breakdown Data by Company
    • 9.2 Rest of World Ankylosing Spondylitis Drug Breakdown Data by Type
    • 9.3 Rest of World Ankylosing Spondylitis Drug Breakdown Data by Application
    • 9.4 Rest of World Ankylosing Spondylitis Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Ankylosing Spondylitis Drug Sales by Countries
      • 9.4.2 Rest of World Ankylosing Spondylitis Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amgen
      • 10.1.1 Amgen Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.1.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.1.5 Amgen Recent Development
    • 10.2 Wyeth
      • 10.2.1 Wyeth Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.2.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.2.5 Wyeth Recent Development
    • 10.3 Takeda
      • 10.3.1 Takeda Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.3.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.3.5 Takeda Recent Development
    • 10.4 Centocor
      • 10.4.1 Centocor Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.4.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.4.5 Centocor Recent Development
    • 10.5 Schering-Plough
      • 10.5.1 Schering-Plough Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.5.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.5.5 Schering-Plough Recent Development
    • 10.6 Mitsubishi Tanabe
      • 10.6.1 Mitsubishi Tanabe Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.6.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.6.5 Mitsubishi Tanabe Recent Development
    • 10.7 Abbott
      • 10.7.1 Abbott Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.7.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.7.5 Abbott Recent Development
    • 10.8 Eisai
      • 10.8.1 Eisai Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.8.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.8.5 Eisai Recent Development
    • 10.9 Pfizer
      • 10.9.1 Pfizer Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.9.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.9.5 Pfizer Recent Development
    • 10.10 Johnson & Johnson
      • 10.10.1 Johnson & Johnson Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Ankylosing Spondylitis Drug
      • 10.10.4 Ankylosing Spondylitis Drug Product Introduction
      • 10.10.5 Johnson & Johnson Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Ankylosing Spondylitis Drug Sales Channels
      • 11.2.2 Ankylosing Spondylitis Drug Distributors
    • 11.3 Ankylosing Spondylitis Drug Customers

    12 Market Forecast

    • 12.1 Global Ankylosing Spondylitis Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Ankylosing Spondylitis Drug Sales Forecast by Type
    • 12.3 Global Ankylosing Spondylitis Drug Sales Forecast by Application
    • 12.4 Ankylosing Spondylitis Drug Forecast by Regions
      • 12.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Ankylosing Spondylitis Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Ankylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.
      In 2019, the market size of Ankylosing Spondylitis Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ankylosing Spondylitis Drug.

      This report studies the global market size of Ankylosing Spondylitis Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Ankylosing Spondylitis Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amgen
      Wyeth
      Takeda
      Centocor
      Schering-Plough
      Mitsubishi Tanabe
      Abbott
      Eisai
      Pfizer
      Johnson & Johnson

      Market Segment by Product Type
      Cimzia
      Enbrel
      Humira
      Remicade
      Simponi
      Others

      Market Segment by Application
      Hospitals
      Clinics

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Ankylosing Spondylitis Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Ankylosing Spondylitis Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Ankylosing Spondylitis Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now